Effects of Physical Therapy Intervention for Children with Acute Lymphoblastic Leukemia

Pediatric Blood and Cancer

Volumn 42, Issue 2, 2004, Pages 127-133

  Marchese, Victoria G ^a,b,c   Chiarello, Lisa A ^c   Lange, Beverly J ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c DREXEL UNIVERSITY   (United States)

Author keywords

Exercise; Leukemia; Physical therapy

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AEROBIC METABOLISM; ANKLE; ARTICLE; BODY MOVEMENT; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDURANCE; EXERCISE; FEMALE; GAIT; HOME CARE; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; LEG; MALE; MUSCLE STRENGTH; PHYSICAL ACTIVITY; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZATION; STRETCHING; TREATMENT OUTCOME;

EID: 0842333175     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10481     Document Type: Article

References (31)

1. Bradley WG, Lassman LP, Pearce GW, et al. The neuromyopathy of vincristine in man clinical, electrophysiological and pathological studies. J Neurol Sci 1970;10:107-131.
2. Sandler SG, Tobin W, Henderson ES. Vincristine-induced neuropathy. Neurology 1969;19:367-374.
3. Vainionpaa L, Kovala T, Tolonen U, et al. Vincristine therapy for children with acute lymphoblastic leukemia impairs conduction in the entire peripheral nerve. Pediatr Neurol 1995;13:314-318.
4. Haim N, Barron SA, Robinson E. Muscle cramps associated with vincristine therapy. Acta Oncol 1991;30:707-711.
5. Hovi L, Era P, Rautonen J, et al. Impaired muscle strength in female adolescents and young adults surviving leukemia in childhood. Cancer 1993;72:276-281.
6. Wright MJ, Halton JM, Martin RF, et al. Long-term gross motor performance following treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 1998;31:86-90.
7. Wright MJ, Halton JM, Barr RD. Limitation of ankle range of motion in survivors of acute lymphoblastic leukemia: A cross-sectional study. Med Pediatr Oncol 1999;32:279-282.
8. Ryan JR, Emami A. Vincristine neurotoxicity with residual equinocavus deformity in children with acute leukemia. Cancer 1983;51:423-425.
9. Mattano LA, Sather HN, Trigg ME, et al. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: A report from the children's cancer group. Clin Oncol 2000;18:3262-3272.
10. Murphy RG, Greenberg ML. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia. Cancer 1990;65:1717-1721.
11. Harlla-Saari AH, Vainionpaa LK, Kovala TT, et al. Nerve lesions after therapy for childhood acute lymphoblastic leukemia. Cancer 1998;82:200-207.
12. Reinders-Messelink H, Schoemaker M, Snijders T, et al. Motor performance of children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol 1999;33:545-550.
13. Van Der Does-Van Den Berg A, De Vaan GAM, Van Weerden JF, et al. Late effects among long-term survivors of childhood acute leukemia in the Netherlands: A Dutch childhood leukemia study group report. Pediatr Res 1995;38:802-807.
14. Vainionpaa L. Clinical neurological findings of children with acute lymphoblastic leukemia at diagnosis and during treatment. Eur Pediatr 1993;152:115-119.
15. Reilly J, Bentham JC, Ralston JM, et al. Reduced energy expenditure in pre-obese children treated for acute lymphoblastic leukemia. Pediatr Res 1998;44:557-562.
16. Brown TR, Madan-Swain A, Pais R, et al. Chemotherapy for acute lymphoblastic leukemia: Cognitive and academic sequelae. J Pediatr 1992;121:885-889.
17. Meadows A, Hobbie W. The medical consequences of the cure. Cancer 1986;58:524-528.
18. Gocha Marchese V, Chiarello LA, Lange BJ. Strength and functional mobility in children with acute lymphoblastic leukemia. Med Pediatr Oncol 2003;40:230-232.
19. Wright MJ, Hanna SE, Halton JM, et al. Maintenance of ankle range of motion in children treated for acute lymphoblastic leukemia. Ped Phys Ther 2003;15:146-152.
20. Effgen SK, Brown DA. Long-term stability of hand-held dynamo-metric measurements in children who have myelomeningocele. Phys Ther 1992;72:458-465.
21. Norkin CC, White DJ. Measurement of joint motion: A guide to goniometry. Philadelphia: F.A. Davis Company; 1985.
22. Lepage C, Noreau L, Bernard PM. Association between characteristics of locomotion and accomplishment of life habits in children with cerebral palsy. Phys Ther 1998;78:458-469.
23. Health related physical fitness: Test manual. Reston, Virginia: American alliance for health, physical education, recreation and dance; 1980.
24. Klepper SE. Effects of an eight-week physical conditioning program on disease signs and symptoms in children with chronic arthritis. Arthritis Care Res 1999;12:52-60.
25. Varni JW, Seid M, Rode CS. The PedsQL measurement model for the pediatric quality of life inventory. Med Care 1999;37:126-139.
26. Winningham ML, MacVicar MG, Burke CA. Exercise for cancer patients: Guidelines and precautions. The Physician and Sports Medicine 1986;14:125-134.
27. Backman E, Odenrick P, Henriksson KG, et al. Isometric muscle force and anthropometric values in normal children aged between 3.5 and 15 years. Scand Rehab Med 1989;21:105-114.
28. American Academy of Orthopaedic Surgeons. Joint motion: Method of measuring and recording. Chicago: AAOS; 1965.
29. Norkin CC, Levangie PK. Joint structure and function: A comprehensive analysis. Philadelphia PA: F.A. Davis Company; 1992.
30. McFayden BJ, Winter DA. An integrated biomechanical analysis of normal stair ascent and descent. J Biomech 1988;21:733-744.
31. Palisano RJ. Validity of goal attainment scaling in infants with motor delays. Phys Ther 1993;73:651-658.